Add to ORKGEfficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-of
Levodopa has been the mainstay of Parkinson's disease (PD) therapy for over 40 years, with its effic...
The efficacy of entacapone and its impact on patient quality of life (QOL) was investigated in an op...
Background and Purpose: Wearing-off is one of the most frequent problems encountered by levodopa-tre...
Paolo Solla, Antonino Cannas, Francesco Marrosu, Maria Giovanna MarrosuMovement Disorders Center, In...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(104) / BLDSC - British Libra...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson's disease (PD) has many possible treatment options. The main therapy uses a drug called le...
The efficacy of entacapone and its impact on patient quality of life (QOL) was investigated in an op...
Parkinson's disease (PD) is a progressive, chronic neurodegenerative disorder. The main neuropatholo...
Levodopa has been the mainstay of Parkinson's disease (PD) therapy for over 40 years, with its effic...
The efficacy of entacapone and its impact on patient quality of life (QOL) was investigated in an op...
Background and Purpose: Wearing-off is one of the most frequent problems encountered by levodopa-tre...
Paolo Solla, Antonino Cannas, Francesco Marrosu, Maria Giovanna MarrosuMovement Disorders Center, In...
Introduction: Parkinson’s disease in its advanced stage is a progressive condition that can be treat...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
SIGLEAvailable from British Library Document Supply Centre-DSC:3578.772(104) / BLDSC - British Libra...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
We performed a 39-week, randomized, double-blind, multicenter study to compare the efficacy, safety,...
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson disease (PD) is a neurodegenerative disorder characterized by 3 cardinal motor symptoms: r...
Parkinson's disease (PD) has many possible treatment options. The main therapy uses a drug called le...
The efficacy of entacapone and its impact on patient quality of life (QOL) was investigated in an op...
Parkinson's disease (PD) is a progressive, chronic neurodegenerative disorder. The main neuropatholo...
Levodopa has been the mainstay of Parkinson's disease (PD) therapy for over 40 years, with its effic...
The efficacy of entacapone and its impact on patient quality of life (QOL) was investigated in an op...
Background and Purpose: Wearing-off is one of the most frequent problems encountered by levodopa-tre...